HCA Healthcare Inc (HCA) is now in the Overvalued zone, suggesting that its current forward PE ratio of 16.02 is considered Overvalued compared with the five-year average of 13.93. The fair price of HCA Healthcare Inc (HCA) is between 443.19 to 522.41 according to relative valuation method. Compared to the current price of 529.70 USD , HCA Healthcare Inc By Overvalued By 1.4%.

Relative Value

Fair Zone

443.19-522.41

Current Price：529.70

1.4%

Overvalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is HCA Healthcare Inc (HCA) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

HCA Healthcare Inc (HCA) has a current Price-to-Book (P/B) ratio of -20.27. Compared to its 3-year average P/B ratio of -35.57, the current P/B ratio is approximately -43.03% higher. Relative to its 5-year average P/B ratio of -25.89, the current P/B ratio is about -21.72% higher. HCA Healthcare Inc (HCA) has a Forward Free Cash Flow (FCF) yield of approximately 7.54%. Compared to its 3-year average FCF yield of 6.43%, the current FCF yield is approximately 17.31% lower. Relative to its 5-year average FCF yield of 6.12%, the current FCF yield is about 23.32% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for HCA competitors is 1.19, providing a benchmark for relative valuation. HCA Healthcare Inc Corp (HCA.N) exhibits a P/S ratio of 1.37, which is 15.54% above the industry average. Given its robust revenue growth of 6.72%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of HCA increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of HCA in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is HCA currently overvalued or undervalued?

What is HCA Healthcare Inc (HCA) fair value?

HCA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of HCA Healthcare Inc (HCA) is between 443.19 to 522.41 according to relative valuation method.

How does HCA's valuation metrics compare to the industry average?

The average P/S ratio for HCA's competitors is 1.19, providing a benchmark for relative valuation. HCA Healthcare Inc Corp (HCA) exhibits a P/S ratio of 1.37, which is 15.54% above the industry average. Given its robust revenue growth of 6.72%, this premium appears unsustainable.

What is the current P/B ratio for HCA Healthcare Inc (HCA) as of Mar 02 2026?

As of Mar 02 2026, HCA Healthcare Inc (HCA) has a P/B ratio of -20.27. This indicates that the market values HCA at -20.27 times its book value.

What is the current FCF Yield for HCA Healthcare Inc (HCA) as of Mar 02 2026?

As of Mar 02 2026, HCA Healthcare Inc (HCA) has a FCF Yield of 7.54%. This means that for every dollar of HCA Healthcare Inc's market capitalization, the company generates 7.54 cents in free cash flow.

What is the current Forward P/E ratio for HCA Healthcare Inc (HCA) as of Mar 02 2026?

As of Mar 02 2026, HCA Healthcare Inc (HCA) has a Forward P/E ratio of 16.02. This means the market is willing to pay $16.02 for every dollar of HCA Healthcare Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for HCA Healthcare Inc (HCA) as of Mar 02 2026?

As of Mar 02 2026, HCA Healthcare Inc (HCA) has a Forward P/S ratio of 1.37. This means the market is valuing HCA at $1.37 for every dollar of expected revenue over the next 12 months.

HCA Valuation